The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.0306-5251.2001.00029.x/fullpdf
Reference16 articles.
1. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction;Boolell;Int J Impot Res,1996
2. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro;Jeremy;Br J Urol,1997
3. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells;Moreland;Life Sci,1998
4. Oral sildenafil in the treatment of erectile dysfunction;Goldstein;N Engl J Med,1998
5. Comparative human pharmacokinetics and metabolism of single dose oral and intravenous sildenafil;Muirhead;Br J Clin Pharmacol,2002
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors;Drug, Healthcare and Patient Safety;2024-07
2. Dynamic Changes in Ion Channels during Myocardial Infarction and Therapeutic Challenges;International Journal of Molecular Sciences;2024-06-12
3. Age-related pharmacokinetics differences were observed between young and elderly populations of a novel PDE5 inhibitor, youkenafil, and its metabolite M459;European Journal of Pharmaceutical Sciences;2024-05
4. Feasibility and Safety of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia (SANE-01): A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Trial;The Journal of Pediatrics;2024-03
5. Macitentan Administration for Pulmonary Hypertension Due to β-thalassemia with Multiple Organ Failure: A Case Report;Internal Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3